Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant bone tumors in children: osteosarcoma.

P A Meyers1

  • 1Department of Pediatrics, Cornell University Medical College, New York, New York.

Hematology/Oncology Clinics of North America
|December 1, 1987
PubMed
Summary

Osteosarcoma, a rare bone cancer, often presents with widespread metastases. Effective treatment combines surgery for the primary tumor and chemotherapy to combat systemic spread, improving survival rates.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review.

British journal of cancer·2014
Same author

Ewing's sarcoma.

Current treatment options in oncology·2002
Same author

Lack of correlation of functional scintigraphy with (99m)technetium-methoxyisobutylisonitrile with histological necrosis following induction chemotherapy or measures of P-glycoprotein expression in high-grade osteosarcoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2001
Same author

High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
Same author

How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001

Area of Science:

  • Oncology
  • Orthopedic Surgery
  • Medical Research

Background:

  • Osteosarcoma is a rare malignant bone tumor characterized by osteoid production.
  • It predominantly affects the metaphyses of long bones.
  • A significant majority (over 80%) of patients present with subclinical metastases at diagnosis.

Purpose of the Study:

  • To outline the essential components of successful osteosarcoma management.
  • To highlight the role of surgical and chemotherapeutic interventions.
  • To discuss the implications of metastatic spread in osteosarcoma prognosis.

Main Methods:

  • Review of established treatment protocols for osteosarcoma.
  • Analysis of surgical techniques, including limb-sparing surgery.
  • Evaluation of the impact of multiagent chemotherapy on patient outcomes.

Main Results:

  • Wide resection of the primary tumor is feasible with limb-sparing surgery.
  • Multiagent chemotherapy has demonstrably improved disease-free survival.
  • While pulmonary metastases can sometimes be surgically controlled, bony metastases are generally fatal.

Conclusions:

  • Successful osteosarcoma management hinges on integrated surgical and chemotherapeutic strategies.
  • Early detection and management of systemic metastases are critical for improving patient outcomes.
  • Prognosis is significantly poorer with the presence of bony metastases compared to pulmonary metastases.

Related Experiment Videos